$4.09 Billion is the total value of Bpifrance SA's 6 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STLA | STELLANTIS NV | $3,715,947,921 | +10.7% | 192,703,907 | 0.0% | 90.95% | +0.8% | |
CSTM | CONSTELLIUM NVcl a | $298,369,035 | +5.8% | 16,393,903 | 0.0% | 7.30% | -3.6% | |
MIRION TECHNOLOGIES INC | $9,609,752 | -11.6% | 1,286,446 | 0.0% | 0.24% | -19.5% | ||
SQNS | SEQUANSCOMMUNICATIONS S Aspons ads | $9,339,051 | +26.9% | 3,300,018 | 0.0% | 0.23% | +15.7% | |
GETAROUND INC | $226,906 | +0.1% | 647,808 | 0.0% | 0.01% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bpifrance Participations SA #1
- Bpifrance Investissement SAS #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CRITEO S A | 20 | Q3 2023 | 10.1% |
TECHNIPFMC PLC | 13 | Q4 2021 | 68.1% |
STELLANTIS NV | 11 | Q3 2023 | 90.9% |
CONSTELLIUM NV | 11 | Q2 2021 | 41.6% |
SEQUANS COMMUNICATIONS S A | 11 | Q2 2021 | 5.8% |
CELLECTIS S.A. | 10 | Q2 2023 | 2.3% |
CONSTELLIUM NV | 9 | Q3 2023 | 8.3% |
SEQUANSCOMMUNICATIONS S A | 9 | Q3 2023 | 0.5% |
MILLENDO THERAPEUTICS INC | 8 | Q3 2020 | 1.8% |
VECTIVBIO HOLDING AG | 8 | Q1 2023 | 0.8% |
View Bpifrance SA's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-13 |
13F-HR | 2023-07-28 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-11 |
View Bpifrance SA's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.